Usefulness of inferior vena cava ultrasonography in outpatients with chronic heart failure

Clin Cardiol. 2018 Apr;41(4):510-517. doi: 10.1002/clc.22915. Epub 2018 Apr 17.

Abstract

Background: Inferior vena cava (IVC) ultrasonography has been used for the diagnosis and prognosis of acute heart failure (HF). Its usefulness in chronic HF is less known.

Hypothesis: IVC ultrasonography is a useful tool in the care of patients with chronic HF.

Methods: For this prospective cohort study, 95 patients with chronic HF were included consecutively as they attended scheduled medical visits. Ultrasound was done with a 5-MHz convex probe device, calculating IVC collapse index (IVCCI). Follow-up time was 1 year. Outcome events were worsening HF, hospital admission for HF, HF mortality, and all-cause mortality.

Results: Worsening HF occurred in 70.9% of patients with IVCCI <30% and 39.1% of patients with IVCCI >50%, with a hazard ratio (HR) of 2.8 (95% CI: 1.3-6.2) adjusted by multivariable analysis. Regarding hospitalization, 45.3% of patients with IVCCI <30% required admission, compared with 5.9% of patients with IVCCI >50%; the adjusted HR was 13.9 (95% CI: 1.7-113.0). Mortality was higher in the IVCCI <30% group, with 25.7% all-cause mortality and 18.6% HF mortality, whereas in the IVCCI >50% group these values were 13% and 4.7%, respectively. However, these differences did not reach statistical significance. ROC analysis was performed and the AUC for IVCCI was not higher than that for NTproBNP for any of the outcomes studied.

Conclusions: IVC ultrasonography is a useful tool in follow-up of patients with chronic HF, allowing identification of patients at high risk of worsening and hospitalization. However, its usefulness is not higher than that of NTproBNP.

Keywords: Chronic Heart Failure; Inferior Vena Cava; POCUS; Ultrasonography.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Ambulatory Care / methods*
  • Area Under Curve
  • Biomarkers / blood
  • Cause of Death
  • Chronic Disease
  • Disease Progression
  • Female
  • Heart Failure / diagnostic imaging*
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Heart Failure / therapy
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Natriuretic Peptide, Brain / blood
  • Outpatients*
  • Patient Admission
  • Peptide Fragments / blood
  • Predictive Value of Tests
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • ROC Curve
  • Reproducibility of Results
  • Risk Factors
  • Time Factors
  • Ultrasonography*
  • Vena Cava, Inferior / diagnostic imaging*
  • Vena Cava, Inferior / physiopathology

Substances

  • Biomarkers
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain